Form 4: Herbalife COO Troy Hicks Executes Stock Transactions
Statement of Changes in Beneficial Ownership
Herbalife Chief Operating Officer Troy Hicks reported the exercise of stock appreciation rights and subsequent sale of common shares.
Summary
- Chief Operating Officer Troy Hicks exercised stock appreciation rights (SARs) for 17,481 shares at $8.31 and 65,789 shares at $9.58.
- A total of 72,626 shares were withheld to cover tax obligations related to the exercises.
- The reporting person sold 38,377 shares at a weighted average price of $12.9325 on May 18, 2026.
- The reporting person sold an additional 10,000 shares at a weighted average price of $12.3245 on May 19, 2026.
- Following these transactions, the reporting person holds 9,706 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the transactions appear to be routine equity compensation management rather than a signal of operational distress or strategic shift.
Positives
- The executive continues to maintain a direct equity stake in the company following the transactions.
Negatives
- The executive reduced his total beneficial ownership through the sale of 48,377 shares in the open market.
Risks
- Market volatility affecting the share price at which future equity-based compensation is realized.
Future Outlook
No specific forward-looking guidance regarding company performance was provided in this filing.
Management Comments
- The reporting person undertakes to provide full information regarding the number of shares sold at each price within the reported ranges upon request.
Industry Context
StockSavvy.ai notes that executive stock sales are common occurrences for liquidity or tax planning purposes and do not necessarily reflect a change in management's outlook on the company's long-term prospects.
Comparison to Industry Standards
- The exercise and sale of equity-based compensation is a standard practice for C-suite executives in publicly traded companies to manage personal financial portfolios.
Stakeholder Impact
- Shareholders should note the reduction in insider holdings, though the volume is consistent with standard executive compensation cycles.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 05/18/2026 | Date of stock appreciation right exercises and initial share sales. |
| 05/19/2026 | Date of secondary share sale. |
| 05/20/2026 | Filing date of the Form 4. |
Keywords
Herbalife, HLF, Insider Trading, Form 4, Stock Appreciation Rights, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.